Stoke Therapeutics【STOK】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

12.24

買値

12.37

売値

12.67

出来高

416,448

12.17 日の範囲 12.51

3.35 52 週間の範囲 17.58

時価総額

644.409M

前日終値

12.26

始値

12.47

時刻

38928

12.24

(average)

最終取引時間

06:47:37

財務取引量

US$ 5,138,010

VWAP

12.3377

平均取引量 (3 か月)

534,477

発行済株式数

52,647,799

配当利回り

PER

-6.15

1 株当たり利益 (EPS)

-1.99

歳入

8.78M

純利益

-104.7M

Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively... Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.stoketherapeutics.com

本社

Dover, Delaware, USA

設立

Stoke Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker STOK. The last closing price for Stoke Therapeutics was US$12.26. Over the last year, Stoke Therapeutics shares have traded in a share price range of US$ 3.35 to US$ 17.58.

Stoke Therapeutics currently has 52,647,799 shares in issue. The market capitalisation of Stoke Therapeutics is US$645.46 million. Stoke Therapeutics has a price to earnings ratio (PE ratio) of -6.15.

全体の流れ

ブルリッシュ

ネットプレミアム

78k

Calls / Puts

100.00%

買い / 売り

100.00%

OTM / ITM

0.00%

Sweeps比率

0.00%

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modification in Dravet Syndrome

– New data showed improvements in cognition and behavior during the first year of treatment with additional increases demonstrated as treatment continued – – Clinical effects observed across the...

Form 4 - Statement of changes in beneficial ownership of securities

Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer

– Mr. Olson brings two decades of successful corporate business development experience with an emphasis on rare diseases and RNA therapeutics – Stoke Therapeutics, Inc. (Nasdaq: STOK), a...

Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy Congress that Demonstrate the Potential for Zorevunersen to be the First Disease-Modifying Medicine for the Treatment of Dravet Syndrome

– First presentation of landmark data from Phase 1/2a and OLE studies of zorevunersen that showed substantial reductions in seizures and continued improvements in multiple measures of cognition...

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that, effective on...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2.9	-19.1545574637	15.14	15.14	12.1	760111	13.18996956	CS
4	-1.75	-12.5089349535	13.99	16.15	12.1	723241	14.43494045	CS
12	-0.28	-2.23642172524	12.52	16.15	12.1	534477	14.37074434	CS
26	1.04	9.28571428571	11.2	17.58	10.35	882962	13.80025196	CS
52	8.3	210.659898477	3.94	17.58	3.35	640825	11.78483008	CS
156	-13.88	-53.1393568147	26.12	33.0635	3.35	409798	12.44381996	CS
260	-9.25	-43.0432759423	21.49	71.58	3.35	306893	16.71137849	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ZCMDZhongchao Inc	US$ 2.1601 (60.60%)	4.63M
GSIWGarden Stage Ltd	US$ 1.60 (32.23%)	5.72M
CMTLComtech Telecommunications Corporation	US$ 5.00 (19.05%)	1.44M
HPHHighest Performances Holdings Inc	US$ 0.8934 (17.31%)	25.26k
GIGMGigaMedia Ltd	US$ 1.69 (16.55%)	589
ENSCEnsysce Biosciences Inc	US$ 0.205 (-28.82%)	232.01k
ADTXAditxt Inc	US$ 0.1362 (-16.60%)	1.96M
HSCSHeart Test Laboratories Inc	US$ 4.55 (-12.33%)	31.05k
MFImF International Ltd	US$ 0.6267 (-11.23%)	156.85k
TBIOTelesis Bio Inc	US$ 2.90 (-10.22%)	96.65k
XPONExpion360 Inc	US$ 0.0653 (-9.56%)	10.52M
INTCIntel Corporation	US$ 23.83 (-0.33%)	6.46M
GSIWGarden Stage Ltd	US$ 1.60 (32.23%)	5.72M
NVDANVIDIA Corporation	US$ 120.63 (-0.63%)	4.86M
ZCMDZhongchao Inc	US$ 2.1601 (60.60%)	4.63M